ABVX
Abivax S.A.
NASDAQ · Healthcare · Biotechnology · FR
$114.01
−0.02%Leverage
- Debt / equity
- 0.10x
- Net debt / equity
- -1.03x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -0.12x
- Net debt / EBITDA
- 1.23x
Liquidity & coverage
- Current ratio
- 7.86x
- Quick ratio
- 7.86x
- Cash ratio
- 6.73x
- Interest coverage
- -12.10x
- EBITDA / interest
- -14.10x
- Working capital
- $628.4M
Cash & dividend
- FCF / debt
- -4.11x
- Cash flow / debt
- -4.10x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025